Coronary interventions

Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.

EuroIntervention 2020;16:e141-e146. DOI: 10.4244/EIJ-D-18-01190

Yuki Katagiri
Yuki Katagiri1, MD; Ryo Torii2, MD; Kuniaki Takahashi1, MD; Erhan Tenekecioglu3, MD; Taku Asano1, MD; Ply Chichareon1, MD; Mariusz Tomaniak3,4, MD; Jan J. Piek1, MD, PhD; Joanna J. Wykrzykowska1, MD, PhD; Nial Bullett5, PhD; Naveed Ahmed5, PhD; Kadem Al-Lamee5, PhD; Rasha Al-Lamee6, MD, PhD; Guy Leclerc7, MD; Pieter Kitslaar8, MSc; Jouke Dijkstra8, PhD; Johan H.C. Reiber8, PhD; Eric K.W. Poon9, PhD; Christos V. Bourantas10,11,12, MD, PhD; Frank J.H. Gijsen13, PhD; Patrick W. Serruys14, MD, PhD; Yoshinobu Onuma14, MD, PhD
1. Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands; 2. Department of Mechanical Engineering, University College London, London, United Kingdom; 3. Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 4. First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland; 5. Arterius Ltd, Leeds, United Kingdom; 6. Imperial College London, London, United Kingdom; 7. AccelLAB Inc., Boisbriand, QC, Canada; 8. LKEB-Division of Image Processing, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; 9. Department of Mechanical Engineering, Melbourne School of Engineering, University of Melbourne, Parkville, Australia; 10. Institute of Cardiovascular Sciences, University College London, London, United Kingdom; 11. Department of Cardiology, Barts Heart Centre, London, United Kingdom; 12. School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; 13. Department of Biomedical Engineering, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 14. Department of Cardiology, National University of Ireland, Galway (NUIG), Galway, Ireland

Aims: The aim of this study was to assess the acute performance of the 95 µm ArterioSorb oriented poly L-lactic acid (PLLA) scaffold in comparison with the XIENCE metallic drug-eluting stent (DES) in porcine coronary arteries.

Methods and results: In 15 non-atherosclerotic Yucatan mini pigs, the ArterioSorb (3.0/14 mm) and XIENCE (3.0/15 mm) were implanted in 25 and 15 vessels, respectively. Acute performance was evaluated by using quantitative coronary angiography (QCA) and optical coherence tomography (OCT). Following three-dimensional reconstruction of the coronary arteries, endothelial shear stress (ESS) was quantified using non-Newtonian steady-flow simulation. Acute recoil measured by QCA was comparable in the two arms. Post-procedural flow and scaffold/stent area by OCT did not differ between the two devices. ESS post procedure was comparable between ArterioSorb and XIENCE (2.21±1.97 vs 2.25±1.71 Pa, p=0.314).

Conclusions: Acute recoil, luminal dimensions and ESS in the ArterioSorb oriented PLLA scaffold with thin struts of 95 µm were comparable to those in the XIENCE metallic DES.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

drug-eluting stentbioresorbable scaffoldsoptical coherence tomographyqca
Coronary interventionsStents and scaffolds
Read next article
Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial

Latest news